Related Experiment Video
Updated: Sep 27, 2025

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice
Published on: July 5, 2021
Recent Status in Brugada Syndrome
1Department of Cardiology, Acıbadem Mehmet Ali Aydınlar University School of Medicine, İstanbul, Turkey.
Brugada syndrome, a genetic heart condition causing sudden death, is characterized by specific ECG changes. This review covers its diagnosis, genetics, risk assessment, and treatment strategies.
Area of Science:
- Cardiology
- Genetics
- Electrophysiology
Background:
- Brugada syndrome is a primary cause of sudden cardiac death (4-12%) in individuals with structurally normal hearts.
- It is an inherited condition with autosomal dominant transmission.
- Over 300 pathogenic variants across 19 genes are linked to Brugada syndrome.
Purpose of the Study:
- To provide a comprehensive overview of Brugada syndrome.
- To focus on current diagnostic criteria, genetic underpinnings, risk stratification methods, and therapeutic approaches.
Main Methods:
- This is a review article.
- Literature search was performed on Brugada syndrome diagnosis, genetics, risk stratification, and management.
Main Results:
- Brugada syndrome presents with characteristic ST-segment elevation in the right precordial leads on an electrocardiogram.
- Genetic factors play a significant role, with numerous identified pathogenic variants.
- Risk stratification and management strategies are crucial for preventing sudden cardiac death.
Conclusions:
- Accurate diagnosis and risk assessment are vital for managing Brugada syndrome.
- Understanding the genetic basis aids in diagnosis and family screening.
- Effective management strategies can mitigate the risk of sudden cardiac death in affected individuals.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations